In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias. Strategies to delay or to reduce dyskinesias are based on the change of levodopa dosing or the early use of dopamine agonists. Dopamine agonists with different pharmacological profile are available. Our paper was aimed to analyse the clinical impact and the management of dyskinesias with dopamine agonists.
机构:
Parkinson's Disease and Movement Disorders Center, Department of Neurology, Ochsner Foundation Clinic, New Orleans, LA 70121Parkinson's Disease and Movement Disorders Center, Department of Neurology, Ochsner Foundation Clinic, New Orleans, LA 70121
机构:
St Joseph Hosp Berlin Weissensee, Dept Neurol, Gartenstr 1, D-13088 Berlin, GermanySt Joseph Hosp Berlin Weissensee, Dept Neurol, Gartenstr 1, D-13088 Berlin, Germany
Mueller, Thomas
Moehr, Jan-Dominique
论文数: 0引用数: 0
h-index: 0
机构:
St Joseph Hosp Berlin Weissensee, Dept Neurol, Gartenstr 1, D-13088 Berlin, GermanySt Joseph Hosp Berlin Weissensee, Dept Neurol, Gartenstr 1, D-13088 Berlin, Germany